OmniAb, Inc. (OABI)
4.35
-0.57
(-11.59%)
USD |
NASDAQ |
Oct 06, 16:00
4.35
0.00 (0.00%)
After-Hours: 20:00
OmniAb EPS Diluted (Quarterly) : -0.0455 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0455 |
| March 31, 2026 | -0.0601 |
| December 31, 2025 | -0.111 |
| September 30, 2025 | -0.144 |
| June 30, 2025 | -0.1496 |
| March 31, 2025 | -0.1723 |
| December 31, 2024 | -0.1247 |
| September 30, 2024 | -0.1599 |
| June 30, 2024 | -0.1344 |
| March 31, 2024 | -0.1882 |
| December 31, 2023 | -0.1403 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.1575 |
| June 30, 2023 | -0.148 |
| March 31, 2023 | -0.0615 |
| December 31, 2022 | 0.0728 |
| September 30, 2022 | -0.1084 |
| June 30, 2022 | -0.0885 |
| March 31, 2022 | -0.0544 |
| December 31, 2021 | -0.0372 |
| September 30, 2021 | -0.0059 |
| June 30, 2021 | -0.0001 |
| March 31, 2021 | -0.0003 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 1.530 |
| Champions Oncology, Inc. | -0.0306 |
| Medpace Holdings, Inc. | 4.250 |
| Charles River Laboratories International, Inc. | -0.0309 |
| Avantor, Inc. | 0.0563 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.859M |
| Revenue (Quarterly) | 13.42M |
| Total Expenses (Quarterly) | 19.27M |
| Enterprise Value | 599.37M |
| Gross Profit Margin (Quarterly) | 64.01% |
| Profit Margin (Quarterly) | -43.68% |
| Earnings Yield | -8.29% |
| Normalized Earnings Yield | -8.393 |